// App-Quantinova.ai

: Exploratory Study of Fibrinolytic Parameters in Patients with JAK2V617F Positive Essential Thrombocythemia

Researchers

Presenter

  • S. Phusanti

Principal Investigators

  • A. Ilich

  • J.D. Beckman

  • A. Sasakul

  • S. Chuncharunee

  • N.S. Key

  • P. Angchaisuksiri

  • P. Chantrathammachart

Medical Centers

  • Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Samut Prakan, Thailand

  • University of North Carolina at Chapel Hill, Chapel Hill, NC, United States

  • University of Minnesota, Minneapolis, MN, United States

  • Chulabhorn Hospital, Bangkok, Thailand

  • Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

Locations

  • Thailand

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Essential thrombocythemia

  • Venous thrombosis

Biomarkers

  • Prostatic acid phosphatase

  • Soluble urokinase plasminogen activator receptor

Drug/Treatment

  • Fibrinogen (IV)

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved